--?報告摘要?--

Welcome to Pharma projects ' 2023 review of trends in pharmaceutical R&D.For over 30 years now， I've been taking an annual look at the evolution of pharma R&D， and in this article， IW examine the state of play at the start of 2023.Well assess industry trends by examining the pipeline by company， therapeutic area， disease，target， and drug type， using data from primarily Pharma projects， part of the Cite line suite of products， which has been tracking global drug development since 1980.This report will be follow ec up by our annual supplement reviewing the New Active Substance launches for the year just passed.But here， we'l tell the story of pharma R&Das it is today：an epic tale， with a rich cast of characters and a global scope， and no doubt a number of unexpected plot twists.Hopefully， it wil be a real page-turner!

--?以上為本文報告前10頁預(yù)覽?--